RSS   Newsletter   Contact   Advertise with us

Chinese vaccine produced by Sinopharm to be available in December for $150

Christian Fernsby ▼ | August 18, 2020
The inactivated coronavirus vaccine produced by the Chinese pharmaceutical corporation Sinopharm will be available on the market in December of this year for about $150, Chairman of Sinopharm Group Liu Jingzhen stated on Tuesday, noting that this will be possible after the third stage of clinical trials is over.
Vaccine   Sinopharm
"After the third stage of international clinical trials ends, we can register the inactivated vaccine. According to our estimations, by the end of the year, it may appear on the market," he said, quoted by Guangming Ribao newspaper. "According to our estimations, the Beijing Institute of Biological Products can produce up to 120 mln inactivated vaccines a year, and the Wuhan Institute of Biological Products can produce an additional 100 mln," he stated.

Topics: Sinopharm

"I have personally received two shots of the vaccine, there were no side effects," Liu Jingzhen informed. "After the inactivated vaccine enters the market, its price will not be too high, it will be around several hundred yuan. Two shots will cost about 1,000 yuan (about $144)," he added.